Abstract
Medication related osteonecrosis of the jaw (MRONJ) is characterized by exposed necrotic bone in the maxillofacial region that persists for more than eight weeks in patients taking antiresorptive or antiangiogenic drugs for bone metastasis or osteoporosis. The management of such condition depends on several factors, among which the staging of MRONJ. Though, a specific gold standard treatment has not been established to date. The aim of this case series is to describe the outcome of surgical treatment of MRONJ with the adjunct of Platelet-rich Fibrin (PRF). Eleven patients under therapy with alendronate underwent surgical removal of necrotic bone and debridement, followed by placement of PRF membranes in the bone defect. The outcome of the surgical treatment was successful in all patients, in a follow-up range from 12 to 36 months. In the cases presented, the macroscopic evaluation showed excellent and fast soft tissue healing, with no recurrence of bone exposure and no signs of infections. PRF membranes were also effective for postsurgical pain control. The use of PRF may represent a valuable adjunct in the surgical management of MRONJ.
| Original language | English |
|---|---|
| Journal | Journal of Stomatology, Oral and Maxillofacial Surgery |
| DOIs | |
| Publication status | Published - Jan 1 2019 |
Fingerprint
Keywords
- Anti-resorptive drugs
- Bisphosphonate-related
- Membranes
- Osteonecrosis of the jaw
- Platelet concentrates
- Platelet-rich fibrin
ASJC Scopus subject areas
- Surgery
- Oral Surgery
- Otorhinolaryngology
Cite this
The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw : A case series. / Fernando de Almeida Barros Mourão, C.; Calasans-Maia, M. D.; Del Fabbro, M.; Le Drapper Vieira, F.; Coutinho de Mello Machado, R.; Capella, R.; Miron, R. J.; Gomes Alves, G.
In: Journal of Stomatology, Oral and Maxillofacial Surgery, 01.01.2019.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw
T2 - A case series
AU - Fernando de Almeida Barros Mourão, C.
AU - Calasans-Maia, M. D.
AU - Del Fabbro, M.
AU - Le Drapper Vieira, F.
AU - Coutinho de Mello Machado, R.
AU - Capella, R.
AU - Miron, R. J.
AU - Gomes Alves, G.
PY - 2019/1/1
Y1 - 2019/1/1
N2 - Medication related osteonecrosis of the jaw (MRONJ) is characterized by exposed necrotic bone in the maxillofacial region that persists for more than eight weeks in patients taking antiresorptive or antiangiogenic drugs for bone metastasis or osteoporosis. The management of such condition depends on several factors, among which the staging of MRONJ. Though, a specific gold standard treatment has not been established to date. The aim of this case series is to describe the outcome of surgical treatment of MRONJ with the adjunct of Platelet-rich Fibrin (PRF). Eleven patients under therapy with alendronate underwent surgical removal of necrotic bone and debridement, followed by placement of PRF membranes in the bone defect. The outcome of the surgical treatment was successful in all patients, in a follow-up range from 12 to 36 months. In the cases presented, the macroscopic evaluation showed excellent and fast soft tissue healing, with no recurrence of bone exposure and no signs of infections. PRF membranes were also effective for postsurgical pain control. The use of PRF may represent a valuable adjunct in the surgical management of MRONJ.
AB - Medication related osteonecrosis of the jaw (MRONJ) is characterized by exposed necrotic bone in the maxillofacial region that persists for more than eight weeks in patients taking antiresorptive or antiangiogenic drugs for bone metastasis or osteoporosis. The management of such condition depends on several factors, among which the staging of MRONJ. Though, a specific gold standard treatment has not been established to date. The aim of this case series is to describe the outcome of surgical treatment of MRONJ with the adjunct of Platelet-rich Fibrin (PRF). Eleven patients under therapy with alendronate underwent surgical removal of necrotic bone and debridement, followed by placement of PRF membranes in the bone defect. The outcome of the surgical treatment was successful in all patients, in a follow-up range from 12 to 36 months. In the cases presented, the macroscopic evaluation showed excellent and fast soft tissue healing, with no recurrence of bone exposure and no signs of infections. PRF membranes were also effective for postsurgical pain control. The use of PRF may represent a valuable adjunct in the surgical management of MRONJ.
KW - Anti-resorptive drugs
KW - Bisphosphonate-related
KW - Membranes
KW - Osteonecrosis of the jaw
KW - Platelet concentrates
KW - Platelet-rich fibrin
UR - http://www.scopus.com/inward/record.url?scp=85062273899&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062273899&partnerID=8YFLogxK
U2 - 10.1016/j.jormas.2019.02.011
DO - 10.1016/j.jormas.2019.02.011
M3 - Article
AN - SCOPUS:85062273899
JO - Journal of Stomatology, Oral and Maxillofacial Surgery
JF - Journal of Stomatology, Oral and Maxillofacial Surgery
SN - 2213-6533
ER -